907 related articles for article (PubMed ID: 34837962)
21. The E2F1/USP11 positive feedback loop promotes hepatocellular carcinoma metastasis and inhibits autophagy by activating ERK/mTOR pathway.
Qiao L; Zhang Q; Sun Z; Liu Q; Wu Z; Hu W; Bao S; Yang Q; Liu L
Cancer Lett; 2021 Aug; 514():63-78. PubMed ID: 34044068
[TBL] [Abstract][Full Text] [Related]
22. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
23. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
24. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway.
Wang J; Yang K; Yang X; Jin T; Tian Y; Dai C; Xu F
Mol Carcinog; 2024 Jul; 63(7):1275-1287. PubMed ID: 38578157
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
Fei X; Zhang P; Pan Y; Liu Y
Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
[TBL] [Abstract][Full Text] [Related]
26. microRNA-874 suppresses tumor proliferation and metastasis in hepatocellular carcinoma by targeting the DOR/EGFR/ERK pathway.
Zhang Y; Wei Y; Li X; Liang X; Wang L; Song J; Zhang X; Zhang C; Niu J; Zhang P; Ren Z; Tang B
Cell Death Dis; 2018 Jan; 9(2):130. PubMed ID: 29374140
[TBL] [Abstract][Full Text] [Related]
27. Magnolol Induces Apoptosis and Inhibits ERK-modulated Metastatic Potential in Hepatocellular Carcinoma Cells.
Kuan LY; Chen WL; Chen JH; Hsu FT; Liu TT; Chen WT; Wang KL; Chen WC; Liu YC; Wang WS
In Vivo; 2018; 32(6):1361-1368. PubMed ID: 30348689
[TBL] [Abstract][Full Text] [Related]
28. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
[TBL] [Abstract][Full Text] [Related]
29. Homeobox B9 Promotes the Progression of Hepatocellular Carcinoma via TGF-
Bai L; Ge P; Zhang Y; Song Y; Xing R; Zhou D
Biomed Res Int; 2022; 2022():1080315. PubMed ID: 36158877
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of cancer susceptibility candidate 2 inhibited progression of hepatocellular carcinoma cells.
Gao X; Du H; Zhang R; Li C; Wang H; Xuan Q; Liu D
J Cell Physiol; 2019 Jun; 234(6):9008-9018. PubMed ID: 30362539
[TBL] [Abstract][Full Text] [Related]
31. Lentivirus-mediated shRNA Targeting CNN2 Inhibits Hepatocarcinoma
Kang X; Wang F; Lan X; Li X; Zheng S; Lv Z; Zhuang Y; Zhao Y; Zhou S
Int J Med Sci; 2018; 15(1):69-76. PubMed ID: 29333089
[No Abstract] [Full Text] [Related]
32. TRB3 interacts with ERK and JNK and contributes to the proliferation, apoptosis, and migration of lung adenocarcinoma cells.
Cao X; Fang X; Malik WS; He Y; Li X; Xie M; Sun W; Xu Y; Liu X
J Cell Physiol; 2020 Jan; 235(1):538-547. PubMed ID: 31256425
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro.
Chen Q; Tan L; Jin Z; Liu Y; Zhang Z
Biomed Res Int; 2020; 2020():3098327. PubMed ID: 32685464
[TBL] [Abstract][Full Text] [Related]
34. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
[TBL] [Abstract][Full Text] [Related]
35. Long Noncoding RNA
Gong X; Zhu Z
Cancer Biother Radiopharm; 2020 Jun; 35(5):387-396. PubMed ID: 32315535
[No Abstract] [Full Text] [Related]
36. Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma.
Sui C; Zhuang C; Sun D; Yang L; Zhang L; Song L
Oncotarget; 2017 Jul; 8(28):45837-45847. PubMed ID: 28507277
[TBL] [Abstract][Full Text] [Related]
37. Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways.
Chen SL; Liu LL; Wang CH; Lu SX; Yang X; He YF; Zhang CZ; Yun JP
Mol Oncol; 2020 Feb; 14(2):373-386. PubMed ID: 31670863
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
[TBL] [Abstract][Full Text] [Related]
40. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
Liao YJ; Bai HY; Li ZH; Zou J; Chen JW; Zheng F; Zhang JX; Mai SJ; Zeng MS; Sun HD; Pu JX; Xie D
Cell Death Dis; 2014 Mar; 5(3):e1137. PubMed ID: 24651440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
